$AGIX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ATHEROGENICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ATHEROGENICS INC. Get notifications about new insider transactions in ATHEROGENICS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 15.30 | 50,000 | 765,000 | 4,135,700 | 4.1 M to 4.1 M (+1.22 %) |
| Aug 11 2005 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Option Exercise | M | 0.10 | 25,000 | 2,500 | 0 | |
| Aug 11 2005 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Buy | M | 0.10 | 25,000 | 2,500 | 360,900 | 335.9 K to 360.9 K (+7.44 %) |
| Jun 16 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 16.32 | 50,000 | 816,000 | 3,915,700 | 3.9 M to 3.9 M (+1.29 %) |
| Jun 14 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 16.44 | 50,000 | 822,000 | 3,865,700 | 3.8 M to 3.9 M (+1.31 %) |
| Jun 10 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 15.58 | 50,000 | 779,000 | 3,765,700 | 3.7 M to 3.8 M (+1.35 %) |
| Jun 10 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 15.59 | 50,000 | 779,500 | 3,715,700 | 3.7 M to 3.7 M (+1.36 %) |
| Jun 01 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 14.63 | 50,000 | 731,500 | 3,665,700 | 3.6 M to 3.7 M (+1.38 %) |
| May 26 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 14.66 | 50,000 | 733,000 | 3,615,700 | 3.6 M to 3.6 M (+1.40 %) |
| May 26 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 14.93 | 50,000 | 746,500 | 3,565,700 | 3.5 M to 3.6 M (+1.42 %) |
| May 19 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 14.60 | 28,900 | 421,940 | 3,515,700 | 3.5 M to 3.5 M (+0.83 %) |
| May 19 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 14.66 | 21,000 | 307,860 | 3,486,800 | 3.5 M to 3.5 M (+0.61 %) |
| May 10 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 13.69 | 100,000 | 1,369,000 | 3,465,700 | 3.4 M to 3.5 M (+2.97 %) |
| May 06 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 12.17 | 50,000 | 608,500 | 3,290,700 | 3.2 M to 3.3 M (+1.54 %) |
| May 06 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 11.76 | 75,000 | 882,000 | 3,240,700 | 3.2 M to 3.2 M (+2.37 %) |
| May 05 2005 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Option Exercise | A | 11.16 | 16,000 | 178,560 | 16,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | SCOTT WILLIAM A | Director | Option Exercise | A | 11.16 | 16,000 | 178,560 | 16,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Option Exercise | A | 11.16 | 16,000 | 178,560 | 16,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | DAGI TAO F | Director | Option Exercise | A | 11.16 | 16,000 | 178,560 | 16,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Option Exercise | A | 11.16 | 16,000 | 178,560 | 16,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | BEARMAN DAVID | Director | Option Exercise | A | 11.16 | 16,000 | 178,560 | 16,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Option Exercise | A | 11.16 | 36,000 | 401,760 | 36,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Option Exercise | M | 0.30 | 25,000 | 7,500 | 160,000 | |
| Apr 29 2005 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Buy | M | 0.30 | 25,000 | 7,500 | 524,641 | 499.6 K to 524.6 K (+5.00 %) |
| Apr 01 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 12.99 | 91,300 | 1,185,987 | 3,115,700 | 3 M to 3.1 M (+3.02 %) |
| Mar 30 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 13.83 | 100,000 | 1,383,000 | 3,024,400 | 2.9 M to 3 M (+3.42 %) |
| Mar 28 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 14.07 | 129,800 | 1,826,286 | 2,924,400 | 2.8 M to 2.9 M (+4.64 %) |
| Mar 23 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Option Exercise | P | 15.00 | 900 | 13,500 | 2,400 | |
| Mar 23 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Option Exercise | P | 15.00 | 250 | 3,750 | 1,500 | |
| Mar 23 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Buy | P | 13.62 | 150,000 | 2,043,000 | 2,794,600 | 2.6 M to 2.8 M (+5.67 %) |
| Mar 21 2005 | AGIX | ATHEROGENICS INC | ATTICUS CAPITAL LLC | 10% Owner | Option Exercise | P | 15.00 | 500 | 7,500 | 1,250 | |
| Feb 28 2005 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Option Exercise | M | 0.10 | 100,000 | 10,000 | 0 | |
| Feb 28 2005 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Sell | S | 17.51 | 100,000 | 1,751,000 | 499,641 | 599.6 K to 499.6 K (-16.68 %) |
| Feb 28 2005 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Buy | M | 0.10 | 100,000 | 10,000 | 599,641 | 499.6 K to 599.6 K (+20.01 %) |
| Feb 28 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance/Admin ... | Sell | S | 17.51 | 39,400 | 689,894 | 0 | 39.4 K to 0 (-100.00 %) |
| Feb 28 2005 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Dev/ ... | Sell | S | 17.51 | 30,000 | 525,300 | 3,900 | 33.9 K to 3.9 K (-88.50 %) |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Option Exercise | M | 0.10 | 75,000 | 7,500 | 25,000 | |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Sell | S | 17.65 | 75,000 | 1,323,750 | 335,900 | 410.9 K to 335.9 K (-18.25 %) |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Buy | M | 0.10 | 75,000 | 7,500 | 410,900 | 335.9 K to 410.9 K (+22.33 %) |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Option Exercise | M | 6.05 | 9,500 | 57,475 | 30,500 | |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Option Exercise | M | 6.04 | 15,500 | 93,620 | 3,500 | |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Sell | S | 17.65 | 9,500 | 167,675 | 0 | 9.5 K to 0 (-100.00 %) |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Buy | M | 6.05 | 9,500 | 57,475 | 9,500 | 0 to 9.5 K |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Sell | S | 17.65 | 15,500 | 273,575 | 0 | 15.5 K to 0 (-100.00 %) |
| Feb 23 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Buy | M | 6.04 | 15,500 | 93,620 | 15,500 | 0 to 15.5 K |
| Jan 04 2005 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Option Exercise | A | 23.56 | 54,000 | 1,272,240 | 54,000 | |
| Jan 04 2005 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Dev ... | Option Exercise | A | 23.56 | 60,000 | 1,413,600 | 60,000 | |
| Jan 04 2005 | AGIX | ATHEROGENICS INC | MONTGOMERY WILLIAM CHARLES | VP of Business Deve ... | Option Exercise | A | 23.56 | 50,000 | 1,178,000 | 50,000 | |
| Jan 04 2005 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Option Exercise | A | 23.56 | 140,000 | 3,298,400 | 140,000 | |
| Jan 04 2005 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Option Exercise | A | 23.56 | 60,000 | 1,413,600 | 60,000 | |
| May 12 2004 | AGIX | ATHEROGENICS INC | BEARMAN DAVID | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | SUDOVAR STEPHEN | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | SCOTT WILLIAM A | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Option Exercise | A | 25.30 | 36,000 | 910,800 | 36,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | DAGI TAO F | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| May 11 2004 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Option Exercise | A | 25.30 | 12,000 | 303,600 | 12,000 | |
| Mar 09 2004 | AGIX | ATHEROGENICS INC | MONTGOMERY WILLIAM CHARLES | VP of Business Deve ... | Option Exercise | A | 19.20 | 50,000 | 960,000 | 50,000 | |
| Mar 09 2004 | AGIX | ATHEROGENICS INC | MONTGOMERY WILLIAM CHARLES | VP of Business Deve ... | Option Exercise | A | 19.20 | 50,000 | 960,000 | 50,000 | |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Option Exercise | M | 7.70 | 10,000 | 77,000 | 0 | |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Option Exercise | M | 7.70 | 20,000 | 154,000 | 0 | |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Option Exercise | M | 6.00 | 19,800 | 118,800 | 0 | |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Buy | M | 7.70 | 10,000 | 77,000 | 109,832 | 99.8 K to 109.8 K (+10.02 %) |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Buy | M | 7.70 | 20,000 | 154,000 | 99,832 | 79.8 K to 99.8 K (+25.05 %) |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | BRYSON VAUGHN D | Director | Buy | M | 6.00 | 19,800 | 118,800 | 79,832 | 60 K to 79.8 K (+32.98 %) |
| Mar 09 2004 | AGIX | ATHEROGENICS INC | MONTGOMERY WILLIAM CHARLES | VP of Business Deve ... | Option Exercise | A | 19.20 | 50,000 | 960,000 | 50,000 | |
| Feb 18 2004 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Sell | S | 20.96 | 79,620 | 1,668,835 | 100,000 | 179.6 K to 100 K (-44.33 %) |
| Feb 18 2004 | AGIX | ATHEROGENICS INC | ALEXANDER R WAYNE | Director | Sell | S | 21.68 | 20,380 | 441,838 | 179,620 | 200 K to 179.6 K (-10.19 %) |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Option Exercise | M | 6.10 | 80,000 | 488,000 | 0 | |
| Feb 24 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Buy | M | 6.10 | 80,000 | 488,000 | 130,000 | 50 K to 130 K (+160.00 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.00 | 1,669 | 36,718 | 50,000 | 51.7 K to 50 K (-3.23 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.06 | 100 | 2,206 | 51,669 | 51.8 K to 51.7 K (-0.19 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.07 | 250 | 5,518 | 51,769 | 52 K to 51.8 K (-0.48 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.08 | 200 | 4,416 | 52,019 | 52.2 K to 52 K (-0.38 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.09 | 2,081 | 45,969 | 52,219 | 54.3 K to 52.2 K (-3.83 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.10 | 700 | 15,470 | 54,300 | 55 K to 54.3 K (-1.27 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.01 | 200 | 4,402 | 55,000 | 55.2 K to 55 K (-0.36 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.00 | 19,800 | 435,600 | 55,200 | 75 K to 55.2 K (-26.40 %) |
| Jan 23 2004 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Option Exercise | M | 7.41 | 7,500 | 55,575 | 22,500 | |
| Jan 23 2004 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Option Exercise | M | 7.04 | 4,800 | 33,792 | 53,600 | |
| Jan 23 2004 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Buy | M | 7.41 | 7,500 | 55,575 | 33,900 | 26.4 K to 33.9 K (+28.41 %) |
| Jan 23 2004 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Buy | M | 7.04 | 4,800 | 33,792 | 26,400 | 21.6 K to 26.4 K (+22.22 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.00 | 1,669 | 36,718 | 50,000 | 51.7 K to 50 K (-3.23 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.06 | 100 | 2,206 | 51,669 | 51.8 K to 51.7 K (-0.19 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.07 | 250 | 5,518 | 51,769 | 52 K to 51.8 K (-0.48 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.08 | 200 | 4,416 | 52,019 | 52.2 K to 52 K (-0.38 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.09 | 2,081 | 45,969 | 52,219 | 54.3 K to 52.2 K (-3.83 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.10 | 700 | 15,470 | 54,300 | 55 K to 54.3 K (-1.27 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.01 | 200 | 4,402 | 55,000 | 55.2 K to 55 K (-0.36 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.00 | 19,800 | 435,600 | 55,200 | 75 K to 55.2 K (-26.40 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.00 | 1,669 | 36,718 | 50,000 | 51.7 K to 50 K (-3.23 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.06 | 100 | 2,206 | 51,669 | 51.8 K to 51.7 K (-0.19 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.07 | 250 | 5,518 | 51,769 | 52 K to 51.8 K (-0.48 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.08 | 200 | 4,416 | 52,019 | 52.2 K to 52 K (-0.38 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.09 | 2,081 | 45,969 | 52,219 | 54.3 K to 52.2 K (-3.83 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.10 | 700 | 15,470 | 54,300 | 55 K to 54.3 K (-1.27 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.01 | 200 | 4,402 | 55,000 | 55.2 K to 55 K (-0.36 %) |
| Feb 11 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 22.00 | 19,800 | 435,600 | 55,200 | 75 K to 55.2 K (-26.40 %) |
| Jan 22 2004 | AGIX | ATHEROGENICS INC | SCOTT WILLIAM A | Director | Option Exercise | M | 7.85 | 3,200 | 25,120 | 12,100 | |
| Jan 22 2004 | AGIX | ATHEROGENICS INC | SCOTT WILLIAM A | Director | Buy | M | 7.85 | 3,200 | 25,120 | 41,800 | 38.6 K to 41.8 K (+8.29 %) |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Option Exercise | M | 9.35 | 5,100 | 47,685 | 10,200 | |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Option Exercise | M | 6.00 | 13,200 | 79,200 | 0 | |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Sell | S | 21.42 | 13,200 | 282,778 | 7,000 | 20.2 K to 7 K (-65.35 %) |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Buy | M | 6.00 | 13,200 | 79,200 | 20,200 | 7 K to 20.2 K (+188.57 %) |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Sell | S | 21.42 | 5,100 | 109,255 | 7,000 | 12.1 K to 7 K (-42.15 %) |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Buy | M | 9.35 | 5,100 | 47,685 | 12,100 | 7 K to 12.1 K (+72.86 %) |
| Feb 17 2004 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Sell | S | 21.62 | 7,619 | 164,723 | 7,000 | 14.6 K to 7 K (-52.12 %) |
| Jan 16 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 18.05 | 5,000 | 90,250 | 75,000 | 80 K to 75 K (-6.25 %) |
| Jan 16 2004 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 18.00 | 20,000 | 360,030 | 80,000 | 100 K to 80 K (-20.00 %) |
| Jan 07 2004 | AGIX | ATHEROGENICS INC | SCOTT WILLIAM A | Director | Option Exercise | M | 6.00 | 6,600 | 39,600 | 0 | |
| Jan 07 2004 | AGIX | ATHEROGENICS INC | SCOTT WILLIAM A | Director | Buy | M | 6.00 | 6,600 | 39,600 | 38,600 | 32 K to 38.6 K (+20.63 %) |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Option Exercise | A | 14.86 | 66,000 | 980,760 | 66,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | MOHR G JOHN | VP Business Develop ... | Option Exercise | A | 14.86 | 20,000 | 297,200 | 20,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | MOHR G JOHN | VP Business Develop ... | Option Exercise | A | 14.86 | 20,000 | 297,200 | 20,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | MOHR G JOHN | VP Business Develop ... | Option Exercise | A | 14.86 | 20,000 | 297,200 | 20,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President and CEO | Option Exercise | A | 14.86 | 120,000 | 1,783,200 | 120,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | MOHR G JOHN | VP Business Develop ... | Option Exercise | A | 14.86 | 20,000 | 297,200 | 20,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP Finance & Adm ... | Option Exercise | A | 14.86 | 57,000 | 847,020 | 57,000 | |
| Jan 05 2004 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP Discovery Res ... | Option Exercise | A | 14.86 | 51,000 | 757,860 | 51,000 | |
| Dec 31 2003 | AGIX | ATHEROGENICS INC | PAPPAS ARTHUR M | Director | Gift | G | 0.00 | 1,500 | 0 | 14,619 | 16.1 K to 14.6 K (-9.31 %) |
| Dec 16 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 13.75 | 951 | 13,076 | 100,000 | 101 K to 100 K (-0.94 %) |
| Nov 20 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 15.21 | 26,951 | 409,909 | 100,000 | 127 K to 100 K (-21.23 %) |
| Nov 20 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 15.21 | 26,951 | 409,909 | 100,000 | 127 K to 100 K (-21.23 %) |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP, Finance & Ad ... | Sell | S | 15.16 | 30,000 | 454,800 | 39,400 | 69.4 K to 39.4 K (-43.23 %) |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP, Finance & Ad ... | Sell | S | 15.16 | 30,000 | 454,800 | 39,400 | 69.4 K to 39.4 K (-43.23 %) |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | COLONNESE MARK P | Sr VP, Finance & Ad ... | Sell | S | 15.16 | 30,000 | 454,800 | 39,400 | 69.4 K to 39.4 K (-43.23 %) |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | MEDFORD RUSSELL M | President & CEO | Sell | S | 15.16 | 75,000 | 1,137,000 | 499,641 | 574.6 K to 499.6 K (-13.05 %) |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP, Discovery Re ... | Option Exercise | M | 6.04 | 31,000 | 187,240 | 19,000 | |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP, Discovery Re ... | Sell | S | 15.16 | 31,000 | 469,960 | 0 | 31 K to 0 (-100.00 %) |
| Nov 19 2003 | AGIX | ATHEROGENICS INC | WASSERMAN MARTIN A | Sr VP, Discovery Re ... | Buy | M | 6.04 | 31,000 | 187,240 | 31,000 | 0 to 31 K |
| Oct 22 2003 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Option Exercise | M | 7.04 | 21,600 | 152,064 | 58,400 | |
| Oct 22 2003 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Buy | M | 7.04 | 21,600 | 152,064 | 21,600 | 0 to 21.6 K |
| Oct 22 2003 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Option Exercise | M | 7.04 | 21,600 | 152,064 | 58,400 | |
| Oct 22 2003 | AGIX | ATHEROGENICS INC | SCOTT ROBERT A | Sr VP Clinical Deve ... | Buy | M | 7.04 | 21,600 | 152,064 | 21,600 | 0 to 21.6 K |
| Oct 10 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 17.54 | 20,000 | 350,800 | 146,951 | 167 K to 147 K (-11.98 %) |
| Oct 10 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 17.60 | 20,000 | 352,066 | 166,951 | 187 K to 167 K (-10.70 %) |
| Oct 14 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 16.81 | 20,000 | 336,124 | 126,951 | 147 K to 127 K (-13.61 %) |
| Oct 14 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 16.81 | 20,000 | 336,124 | 126,951 | 147 K to 127 K (-13.61 %) |
| Oct 08 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 17.12 | 20,000 | 342,460 | 186,951 | 207 K to 187 K (-9.66 %) |
| Oct 08 2003 | AGIX | ATHEROGENICS INC | HENOS MICHAEL A | Director | Sell | S | 17.27 | 20,000 | 345,400 | 206,951 | 227 K to 207 K (-8.81 %) |